Article
Using the Epigenetic Field Defect to Detect Prostate Cancer in Biopsy Negative Patients
15 Nov 2012
Abstract excerpt
PURPOSE: We determined whether a novel combination of field defect DNA methylation markers could predict the presence of prostate cancer using histologically normal transrectal ultrasound guided biopsy cores. MATERIALS AND METHODS: Methylation was assessed using quantitative Pyrosequencing® in a training set consisting of 65 nontumor and tumor associated prostate tissues from University of Wisconsin. A multiplex...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
